Nov 5, 2025, 3-5PM ET
Wednesday on The Robert Scott Bell Show:
On this episode of The Robert Scott Bell Show, things kicked off with a hilarious “Name That Pepper” segment after Diane emailed asking what kind of peppers Robert had sent her from his garden during last month’s Patreon AMA giveaway. With Super Don and Mark D chiming in, it turned into a spicy guessing game that reminded everyone why homegrown food and laughter are some of the best forms of medicine.
Then, longtime friend and health innovator Paul Barattiero joined Robert in-studio to dive deep into the science behind Echo hydrogen water and how it supports brain health, cognitive function, and overall healing. From dementia and Parkinson’s to gut-brain balance, Paul broke down how hydrogen stimulates ghrelin production and why water might be the simplest and most powerful way to help the body heal itself.
The discussion expanded to Paul’s latest breakthrough – hydrogen-infused baths and Echo inhalation systems, helping with skin health, inflammation, and recovery. Robert and Paul even laughed about how celebrities like The Rock and Leonardo DiCaprio are using hydrogen baths, proving that “bubbling up health” isn’t just hype – it’s real innovation.
Paul also revealed how his Lumanova red light therapy beds outperform competitors, exposing misleading claims in the red light industry and showing what true therapeutic results look like. He and Robert reflected on their 16-year friendship, shared stories about their first cars, and celebrated how far natural innovation has come since the early days of Echo Water.
The hour wrapped with powerful reflections on faith, freedom, and gratitude – from the growing alliance between Trump and Kennedy to Bill Gates’ recent climate “backtrack.” Paul offered to personally buy Thanksgiving dinners for families in need, reminding listeners what genuine service and compassion look like. A full hour of truth, laughter, and heart – because once again, the power to heal is yours.
Hour 2 ENCORE!
Special Guest Dr. Kirk Moore
Dr. Michael Kirk Moore, M.D., is a respected board-certified plastic surgeon in Utah, known for his surgical skill, compassionate care, and dedication to the well-being of his patients. Over the course of his career, he has built a reputation for excellence in both cosmetic and reconstructive procedures, combining advanced training with a patient-first philosophy that emphasizes trust, attentiveness, and dignity.
In 2023, Dr. Moore found himself at the center of a high-profile federal case when prosecutors accused him and others of participating in a COVID-19 vaccine-related scheme. While the government sought to portray him as a criminal, Dr. Moore consistently maintained his innocence, standing firm in his convictions and defending his right to medical freedom and personal integrity. His case drew national attention, raising questions about federal overreach, patient choice, and the balance between regulation and individual liberty during a time of crisis.
After more than two years of legal battles, the Department of Justice dropped all charges against Dr. Moore in July 2025. This outcome affirmed what his supporters had long believed—that he was unjustly targeted and that the case against him did not stand. His vindication has only strengthened his resolve to continue serving patients with the same compassion, honesty, and dedication that have defined his career.
Today, Dr. Moore remains committed to his profession, his patients, and the principles of medical ethics and freedom. For many, his story is not just one of legal triumph, but of courage in the face of immense pressure, and a reminder that integrity and truth can prevail even against overwhelming odds.
FDA Chief Says No Solid Evidence Supporting Hepatitis B Vaccine at Birth FDA Commissioner Dr. Marty Makary stated on September 8 that he believes there is not solid evidence to support administering the hepatitis B vaccine to all newborns at birth. He acknowledged the importance of vaccines generally but emphasized that not all vaccines necessarily require immediate newborn administration and cited hepatitis B—primarily a sexually transmitted infection—as one such case. Makary suggested that some parents might prefer to delay the first dose until children reach ages when sexual transmission is more plausible, such as 10 to 12 years old, though he noted the recommendation for at-risk infants (i.e., born to mothers who are hepatitis B positive) should remain unchanged. His comments come ahead of the Advisory Committee on Immunization Practices (ACIP) meeting scheduled for mid-September, where the policy on newborn hepatitis B vaccination may be reconsidered. Dr. Demetre Daskalakis, recently departed from the CDC, countered that delaying the birth dose poses risks, especially when maternal hepatitis status is unknown at delivery. He highlighted data showing that between 20,000 to 25,000 U.S. infants are born annually to infected mothers—an infection that can lead to chronic liver disease and cancer later in life. The current CDC guidance recommends that all infants receive the hepatitis B vaccine shortly after birth. Through that protocol, the vaccine has been credited with drastically reducing perinatal transmission and associated lifelong health consequences.
RFK Jr. May Link Vax Aluminum Adjuvant and Autism, Former FDA Chief Says Former FDA Commissioner Scott Gottlieb warned in a CNBC interview that Health and Human Services Secretary Robert F. Kennedy Jr. may use a forthcoming agency report to allege a link between aluminum-based adjuvants, such as alum, and autism, a claim Gottlieb suggested could “take down the whole pediatric vaccine enterprise.” Gottlieb explained that alum is used in roughly 10 vaccines and that there is no suitable alternative currently available. He cautioned that if manufacturers were forced to reformulate or separate combination vaccines like MMR, children would need additional shots, increasing the number of clinical visits and potentially depressing vaccination rates overall. Gottlieb, who disclosed his position on Pfizer’s board, stressed that the issue extends beyond one company, as alum is widespread across the vaccine portfolio. His remarks come amid heightened scrutiny of autism’s potential environmental or pharmaceutical contributors under Kennedy’s tenure. While Kennedy has spotlighted possible links such as acetaminophen use in pregnancy, mainstream scientific consensus remains firm that vaccines are not a driver of autism. Just weeks earlier, a 24-year Danish cohort study of 1.2 million children published in Annals of Internal Medicine found no association between aluminum adjuvants in vaccines and increased risk for 50 health outcomes. Despite such findings, Kennedy’s upcoming report is expected to explore aluminum, Tylenol use, folate deficiencies, and possible therapies like leucovorin for autism symptoms. HHS has pushed back against speculation, emphasizing that conclusions will rest on “gold-standard science” once the report is finalized.
Two Vaccination Systems: ACOG vs. CDC and the Growing Divide in U.S. Public Health The article examines a deepening rift in U.S. public health policy highlighted by contrasting COVID-19 vaccination recommendations from the American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC). ACOG recently issued strong guidance endorsing COVID-19 vaccination during pregnancy, citing established safety data, while the CDC maintained a more reserved, “shared clinical decision‐making” stance, reflecting caution amid evolving evidence. The divergence reflects broader tensions within public health institutions, where medical specialty organizations may prioritize direct clinical judgment and individualized care, while federal agencies must balance epidemiological trends, regulatory caution, and policy consistency. Critics argue that such discrepancies generate public confusion and erode trust, especially when expectant mothers receive mixed messaging from authoritative bodies. In response, ACOG defended its position by pointing to substantial studies demonstrating that vaccination during pregnancy reduces the risk of severe COVID-19 outcomes and remains safe for both mother and fetus. The CDC responded that its guidance is designed to accommodate evolving data and ensure flexibility across varied clinical contexts. Public health analysts warn that if differing recommendations become more common across specialties, the U.S. risks fragmenting vaccine policy and undermining cohesive strategies for population health. The article concludes that reconciling these differences—or at least improving communication between specialist groups and federal agencies—is essential to maintaining public trust and ensuring unified public health guidance.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we examine Mephitis Putorius—prepared from the secretion of the skunk.
In crude form, its strong odor and irritating effects are notorious. In potency, it becomes a remarkable homeopathic remedy for violent respiratory spasms, suffocative attacks, and coughs that threaten to choke.
Download the Information Sheet
Remember Friends, The Power to Heal is Yours!
